Reciprocal Dynamics of Metabolism and MRNA Translation in Tumor Angiogenesis

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Oct 26

PMID 39457064

Authors

Jacopo Lidonnici

Roxana E Oberkersch

Affiliations

Soon will be listed here.

Abstract

Angiogenesis, the process of formation of new blood vessels from pre-existing vasculature, is essential for tumor growth and metastasis. Anti-angiogenic treatment targeting vascular endothelial growth factor (VEGF) signaling is a powerful tool to combat tumor growth; however, anti-tumor angiogenesis therapy has shown limited efficacy, with survival benefits ranging from only a few weeks to months. Compensation by upregulation of complementary growth factors and switches to different modes of vascularization have made these types of therapies less effective. Recent evidence suggests that targeting specific players in endothelial metabolism is a valuable therapeutic strategy against tumor angiogenesis. Although it is clear that metabolism can modulate the translational machinery, the reciprocal relationship between metabolism and mRNA translational control during tumor angiogenesis is not fully understood. In this review, we explore emerging examples of how endothelial cell metabolism affects mRNA translation during the formation of blood vessels. A deeper comprehension of these mechanisms could lead to the development of innovative therapeutic strategies for both physiological and pathological angiogenesis.

References

Berg M, Brandl C . Transfer RNAs: diversity in form and function. RNA Biol. 2020; 18(3):316-339. PMC: 7954030. DOI: 10.1080/15476286.2020.1809197. View

Kim B, Li J, Jang C, Arany Z . Glutamine fuels proliferation but not migration of endothelial cells. EMBO J. 2017; 36(16):2321-2333. PMC: 5556269. DOI: 10.15252/embj.201796436. View

Sood R, Porter A, Olsen D, Cavener D, Wek R . A mammalian homologue of GCN2 protein kinase important for translational control by phosphorylation of eukaryotic initiation factor-2alpha. Genetics. 2000; 154(2):787-801. PMC: 1460965. DOI: 10.1093/genetics/154.2.787. View

Lopes-Coelho F, Martins F, Pereira S, Serpa J . Anti-Angiogenic Therapy: Current Challenges and Future Perspectives. Int J Mol Sci. 2021; 22(7). PMC: 8038573. DOI: 10.3390/ijms22073765. View

Bartish M, Abraham M, Goncalves C, Larsson O, Rolny C, del Rincon S . The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment. Nat Rev Cancer. 2023; 23(6):408-425. DOI: 10.1038/s41568-023-00567-5. View

Pike L, Smift A, Croteau N, Ferrick D, Wu M . Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta. 2011; 1807(6):726-34. DOI: 10.1016/j.bbabio.2010.10.022. View

Fu H, Feng J, Liu Q, Sun F, Tie Y, Zhu J . Stress induces tRNA cleavage by angiogenin in mammalian cells. FEBS Lett. 2008; 583(2):437-42. DOI: 10.1016/j.febslet.2008.12.043. View

Jia Z, Zhang Y, Li Q, Ye Z, Liu Y, Fu C . A coronary artery disease-associated tRNAThr mutation altered mitochondrial function, apoptosis and angiogenesis. Nucleic Acids Res. 2018; 47(4):2056-2074. PMC: 6393294. DOI: 10.1093/nar/gky1241. View

Wang G, Li Z, Li Z, Huang Y, Mao X, Xu C . Targeting eIF4E inhibits growth, survival and angiogenesis in retinoblastoma and enhances efficacy of chemotherapy. Biomed Pharmacother. 2017; 96:750-756. DOI: 10.1016/j.biopha.2017.10.034. View

10.

Gorski D, Beckett M, Jaskowiak N, Calvin D, Mauceri H, Salloum R . Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 1999; 59(14):3374-8. View

11.

Cross M, Claesson-Welsh L . FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci. 2001; 22(4):201-7. DOI: 10.1016/s0165-6147(00)01676-x. View

12.

Ye J, Kumanova M, Hart L, Sloane K, Zhang H, De Panis D . The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J. 2010; 29(12):2082-96. PMC: 2892366. DOI: 10.1038/emboj.2010.81. View

13.

Ho J, Lee S . A Cap for Every Occasion: Alternative eIF4F Complexes. Trends Biochem Sci. 2016; 41(10):821-823. PMC: 5045779. DOI: 10.1016/j.tibs.2016.05.009. View

14.

Zhang P, McGrath B, Reinert J, Olsen D, Lei L, Gill S . The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice. Mol Cell Biol. 2002; 22(19):6681-8. PMC: 134046. DOI: 10.1128/MCB.22.19.6681-6688.2002. View

15.

Chen Q, Shen L, Liao T, Qiu Y, Lei Y, Wang X . A Novel tRNA-Derived Fragment, tRF, Regulates Angiogenesis by Targeting Antxr1 mRNA. Int J Mol Sci. 2023; 24(19). PMC: 10572189. DOI: 10.3390/ijms241914552. View

16.

Teleanu R, Chircov C, Grumezescu A, Teleanu D . Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment. J Clin Med. 2020; 9(1). PMC: 7020037. DOI: 10.3390/jcm9010084. View

17.

Huang H, Vandekeere S, Kalucka J, Bierhansl L, Zecchin A, Bruning U . Role of glutamine and interlinked asparagine metabolism in vessel formation. EMBO J. 2017; 36(16):2334-2352. PMC: 5556263. DOI: 10.15252/embj.201695518. View

18.

Poltorack C, Dixon S . Understanding the role of cysteine in ferroptosis: progress & paradoxes. FEBS J. 2021; 289(2):374-385. PMC: 8473584. DOI: 10.1111/febs.15842. View

19.

Statzer C, Meng J, Venz R, Bland M, Robida-Stubbs S, Patel K . ATF-4 and hydrogen sulfide signalling mediate longevity in response to inhibition of translation or mTORC1. Nat Commun. 2022; 13(1):967. PMC: 8857226. DOI: 10.1038/s41467-022-28599-9. View

20.

Boccaletto P, Stefaniak F, Ray A, Cappannini A, Mukherjee S, Purta E . MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res. 2021; 50(D1):D231-D235. PMC: 8728126. DOI: 10.1093/nar/gkab1083. View